A systematic literature review of herpes zoster incidence worldwide

Hum Vaccin Immunother. 2021 Jun 3;17(6):1714-1732. doi: 10.1080/21645515.2020.1847582. Epub 2021 Mar 2.

Abstract

We conducted a systematic review to characterize the incidence rate of herpes zoster (HZ) in the general population, specifically in individuals ≥50 years of age. A total of 69 publications were included in the review. We found a cumulative incidence of HZ ranging from 2.9-19.5 cases per 1,000 population and an incidence rate of HZ ranging from 5.23-10.9 cases per 1,000 person-years. The cumulative incidence (3.22-11.2 versus 2.44-8.0 cases per 1,000 population) and incidence rates (6.05-12.8 versus 4.30-8.5 cases per 1,000 person-years) were higher in females than males. Studies revealed a trend of increasing incidence of HZ with increasing age and over time. Variations in incidence estimates can be attributed to the various study designs, case ascertainments, age distributions of the population and year of the study. HZ is associated with a substantial disease burden and is expected to increase due to population aging.

Keywords: Incidence; adults; epidemiology; herpes zoster; review; shingles; vaccination.

Publication types

  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Age Distribution
  • Cost of Illness
  • Female
  • Herpes Zoster Vaccine*
  • Herpes Zoster*
  • Herpesvirus 3, Human
  • Humans
  • Incidence
  • Male

Substances

  • Herpes Zoster Vaccine

Grants and funding

GlaxoSmithKline Biologicals SA funded this study (GSK study identifier: HO-18-19810) and was involved in all stages of study conduct, including analysis of the data. GlaxoSmithKline Biologicals SA also paid all costs associated with the development and publication of this manuscript